2026 NPPES data Hematology & Oncology Physician NPI 1942641097 M.D.
Verify on CMS →

JEAN BUSTAMANTE, M.D.

Hematology & Oncology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
639
Medicare Part D claims · 166 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
51%
generic claims · 49% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.15/100
▲ 16 pts above national avg 83.1 · [object Object]
What the federal data reveals: JEAN BUSTAMANTE, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 639 claims across 166 beneficiaries — 49% brand-name prescribing . Their CMS MIPS Final Score of 99.15/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: JEAN BUSTAMANTE, M.D. reported a CMS MIPS final score of 99.15 out of 100, above the 83.1 national average, and filed 639 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

JEAN BUSTAMANTE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

JEAN BUSTAMANTE, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 07/17/2013

NPI 1942641097

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

639 25% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

99.15/100 16.05000000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers

Hematology & Oncology Physician share within New York

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New York

Medicare quality performance — MIPS

JEAN BUSTAMANTE, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
99.15/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 99.15/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Hematology & Oncology Physician) — 99.15/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JEAN BUSTAMANTE, M.D. is a Hematology & Oncology Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1942641097. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JEAN BUSTAMANTE, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 215 E 95TH ST FRNT 2, NEW YORK, NY, 10128, with a listed phone of (718) 732-4049. NPI 1942641097 was issued on 07/17/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BUSTAMANTE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 639 prescription claims written by this provider, covering 166 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.15/100 for the 2023 performance year, compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

215 E 95TH ST FRNT 2
NEW YORK, NY 10128

Provider Details

NPI 1942641097
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 07/17/2013

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.15
Final Score
Avg: 83.1
99
Promoting Interoperability

Reporting: Group practice

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to JEAN BUSTAMANTE, M.D.. To verify JEAN BUSTAMANTE, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JEAN BUSTAMANTE, M.D. — brand share 49.0%
Specialty average (est.)

49% brand-name claims vs 51% generic, on 639 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

639
Total Claims
$2.5M
Total Drug Cost
166
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
833
Total Day Supply
20,984
Brand vs Generic
49% brand / 51% generic
Brand Drug Cost
$2.5M
Generic Drug Cost
$81K
Antibiotic Claims
25

Patient Demographics

Average Patient Age
75.0 years
Avg HCC Risk Score
2.66
Gender Split
63% female / 37% male
Age Distribution
<65: 17, 65-74: 64, 75-84: 58, 85+: 27

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Procrit
Epoetin Alfa
54
Dexamethasone
36
Ondansetron Hcl
29
Eliquis
Apixaban
25
Prochlorperazine Maleate
23
Prednisone
20
Aranesp
Darbepoetin Alfa In Polysorbat
19
Akynzeo
Fosnetupitant/Palonosetron
18
Pantoprazole Sodium
18
Xalkori
Crizotinib
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How JEAN BUSTAMANTE, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

JEAN BUSTAMANTE, M.D.'s 639 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as BUSTAMANTE.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JEAN BUSTAMANTE, M.D.'s specialty?
JEAN BUSTAMANTE, M.D. specializes in Hematology & Oncology Physician and practices in NEW YORK, New York. Credentials: M.D..
How much does JEAN BUSTAMANTE, M.D. prescribe under Medicare Part D?
In 2023, JEAN BUSTAMANTE, M.D. wrote 639 Medicare Part D claims totaling $2.5M in drug costs for 166 beneficiaries.
What is JEAN BUSTAMANTE, M.D.'s Medicare quality score?
JEAN BUSTAMANTE, M.D. has a CMS MIPS Final Score of 99.15/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JEAN BUSTAMANTE, M.D. located?
JEAN BUSTAMANTE, M.D. is located at 215 E 95TH ST FRNT 2, NEW YORK, NY, 10128. Phone: (718) 732-4049.
What is JEAN BUSTAMANTE, M.D.'s NPI number?
JEAN BUSTAMANTE, M.D.'s National Provider Identifier (NPI) is 1942641097, issued on 07/17/2013.
Does JEAN BUSTAMANTE, M.D. prescribe more brand-name or generic drugs?
JEAN BUSTAMANTE, M.D.'s prescribing is 49% brand-name and 51% generic drugs by claim count, with $2.5M in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does JEAN BUSTAMANTE, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JEAN BUSTAMANTE, M.D.'s most frequently prescribed drugs include Procrit, Dexamethasone, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JEAN BUSTAMANTE, M.D. accept Medicare?
JEAN BUSTAMANTE, M.D. appears in CMS Medicare data with 639 Part D claims and 166 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JEAN BUSTAMANTE, M.D.'s credentials?
JEAN BUSTAMANTE, M.D.'s NPI is 1942641097 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology